Annual Meeting On-Demand - Short Course #20 - Algorithmic Approach to Cystic and Solid Pancreatic Cytology: A Case-Based Interpretation

This course offers a comprehensive introduction to the cytopathology of cystic and solid pancreatic lesions. It begins with an overview of an algorithmic approach, emphasizing the integration of radiologic features, cytomorphologic findings, and ancillary tests in this context. This session also includes a review of the evolving reporting systems, transitioning from the Papanicolaou Society of Cytopathology (PSC) to the World Health Organization (WHO).

The course then shifts into an interactive case-based discussion on cystic pancreatic lesions. Participants will explore fascinating cases, including serous cystadenoma (benign category), neoplastic mucinous cyst with low-grade atypia (PaN-Low category), neoplastic mucinous cyst with high-grade atypia (PaN-High category), and solid pseudopapillary neoplasm with cystic degeneration (positive for malignancy category).

This will be followed by an engaging showcase of solid pancreatic lesions through four case studies: pancreatic ductal adenocarcinoma, acinar cell carcinoma, neuroendocrine tumor, and metastatic malignancy (all positive for malignancy categories).

The session concludes with a dedicated Q&A segment, providing participants the opportunity to clarify doubts and engage with the faculty. Finally, participants can test their knowledge in an exciting summative quiz, with a chance to win prizes.

Target Audience

This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.

Learning Objectives

  • Recognize key diagnostic findings for solid and cystic pancreatic lesions
  • Learn a practical algorithmic approach to the diagnosis of solid and cystic pancreatic lesions, with integration of clinical, radiologic, and cytologic features and ancillary testing
  • Communicate cytologic results using WHO Reporting System for Pancreaticobiliary Cytopathology to appropriately guide clinical management
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 California Credits
  • 1.50 CMLE
  • 1.50 Florida Credits
  • 1.50 Participant
Course opens: 
01/01/2026
Course expires: 
12/31/2028
Cost:
$125.00

Presenter(s):
Raza Hoda, MD
Seyedreza Mousavi, MD, MS, CT(ASCP), MB, CT(IAC) 

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.

The following individuals have reported financial relationships:
Israh Akhtar, MD, FIAC: Consultant - Astra Zeneca
Zaibo Li, MD, PhD: Consultant - PathAI, AlxMed; Board of Directors - Digital Pathology Association
Paul VanderLaan, MD, PhD: Consultant – Gala Therapeutics

The following individuals have reported no relevant financial relationships:
Kristen Atkins, MD, Catherine Bammert, PhD, CT, MB(ASCP), CT(IAC), Christine Booth, MD, Marilyn Bui, MD, PhD, Amy Clayton, MD, Jacqueline Cuda, BS, SCT(ASCP), Fang Fan, MD, PhD, Beverly Haigler-Daly, BS, CT(ASCP), Michael Henry, MD, Angelique Levi, MD, Xiaoying Liu, MD, Abberly Lott Limbach, MD, Maria Cecilia Lozano, MD, PhD, MIAC, Varsha Manucha, MD, Sean McNair, MPH, CT(ASCP), Sara Monaco, MD, Maheswari Mukherjee, PhD, MSc, BPT, SCT(ASCP)CM, Dianna Ng, MD, Michiya Nishino, MD, PhD, Christopher O'Conor, MD, PhD, Melissa Randolph, BS, SCT(ASCP), Michelle Reid, MD, MSc, Marilin Rosa, MD, Sinchita Roy-Chowdhuri, MD, PhD, Momin Siddiqui, MD, FIAC, Zoon Tariq, MD, Michael Thrall, MD, Gary Tse, MBBS, Christopher VandenBussche, MD, PhD, Philippe Vielh, MD, PhD, Joe Walker, Jr, MS, SCT(ASCP), Vivian Weiss, MD, PhD, Lisa Zhang, Raza Hoda, MD, Seyedreza Mousavi, MD, MS, CT(ASCP), MB, CT(IAC)

The ASC staff associated with the development of content for this activity reported no relevant financial relationships.

ACCREDITATION AND DESIGNATION STATEMENTS

Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The American Society of Cytopathology designates this enduring educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

American Board of Pathology Maintenance of Certification (CC)
This product can help fulfill the CME requirements mandated by the American Board of Pathology Continuing Certification (CC) process.  Earn up to 1.5 Credit Hours.

Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 1.5 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians.  The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Cytotechnologists with Licenses in Florida and California
This program is approved for 1.5 continuing education credits in the States of Florida and California.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 California Credits
  • 1.50 CMLE
  • 1.50 Florida Credits
  • 1.50 Participant

Price

Cost:
$125.00
Please login or register to take this course.